DE3560366D1 - Compositions containing oligo-muramylpeptides and their application, in particular for the activation of macrophages - Google Patents

Compositions containing oligo-muramylpeptides and their application, in particular for the activation of macrophages

Info

Publication number
DE3560366D1
DE3560366D1 DE8585400080T DE3560366T DE3560366D1 DE 3560366 D1 DE3560366 D1 DE 3560366D1 DE 8585400080 T DE8585400080 T DE 8585400080T DE 3560366 T DE3560366 T DE 3560366T DE 3560366 D1 DE3560366 D1 DE 3560366D1
Authority
DE
Germany
Prior art keywords
muramylpeptide
macrophages
activation
combined
hapten
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585400080T
Other languages
English (en)
Inventor
Claude Leclere
Georges Bahr
Louis Chedid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Application granted granted Critical
Publication of DE3560366D1 publication Critical patent/DE3560366D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8585400080T 1984-01-17 1985-01-17 Compositions containing oligo-muramylpeptides and their application, in particular for the activation of macrophages Expired DE3560366D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400676A FR2558165B1 (fr) 1984-01-17 1984-01-17 Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages

Publications (1)

Publication Number Publication Date
DE3560366D1 true DE3560366D1 (en) 1987-08-27

Family

ID=9300201

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585400080T Expired DE3560366D1 (en) 1984-01-17 1985-01-17 Compositions containing oligo-muramylpeptides and their application, in particular for the activation of macrophages

Country Status (5)

Country Link
EP (1) EP0149581B1 (de)
JP (1) JPS60161926A (de)
AT (1) ATE28477T1 (de)
DE (1) DE3560366D1 (de)
FR (1) FR2558165B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A3 (de) * 1984-03-01 1987-07-01 Centocor, Inc. Steigerung der Antigenimmunogenität mittels Antikörper
US4879225A (en) * 1986-06-20 1989-11-07 Neorx Corporation Enhanced production of antibodies utilizing insolubilized immune complexes
CN1034986C (zh) * 1993-04-22 1997-05-28 上海医科大学 一种新型免疫原性复合物制剂及制备方法
JP3669758B2 (ja) * 1995-06-15 2005-07-13 ユニ・チャーム株式会社 蓋装置
EP3323424A1 (de) 2016-11-17 2018-05-23 Cyanimal IP Cyaa-polypeptide als immunomodulatorenverstärker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Also Published As

Publication number Publication date
FR2558165B1 (fr) 1986-07-04
EP0149581A2 (de) 1985-07-24
FR2558165A1 (fr) 1985-07-19
EP0149581B1 (de) 1987-07-22
JPS60161926A (ja) 1985-08-23
EP0149581A3 (en) 1985-08-28
ATE28477T1 (de) 1987-08-15

Similar Documents

Publication Publication Date Title
DE2964794D1 (en) Radiation curable silicon release compositions, their use in making coated articles and laminates and the articles and laminates produced thereby
DE3853191D1 (de) Arzneimittelträger.
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
DE3873616D1 (de) Polyacetal-harzzusammensetzung und daraus hergestellte gleitteile.
FR2299087A1 (fr) Dispositif pour l'evacuation de matieres, en particulier d'epluchures et ordures menageres
ZA767203B (en) Film forming composition for sunscreens and the like
ZA816555B (en) Novel benzoxazolinones,substituted in the 6-position by an amino-alcohol chain or amino-ketone chain,their preparation and their use in pharmaceutical preparations
IT8023526A0 (it) Procedimento per l'assorbimento di contaminanti, difetti o simili in un corpo semiconduttore.
DE3560366D1 (en) Compositions containing oligo-muramylpeptides and their application, in particular for the activation of macrophages
JPS57122054A (en) Tridecapeptide and manufacture
DE3670632D1 (de) Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
JPS5569615A (en) Novel composition for manufacturing elastmeric urethaneeurea copolymer and its manufacture
GB2014141B (en) 8 -ethyl and 8 -methyl 4,5a-epoxymorphinan -6- one compounds
IL57033A0 (en) Tricyclic 1,3-dioxanes and perfume compositions containingthem
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
IL61223A0 (en) Tricyclo(6.2.1.01,6)undecanes, their preparation and perfume compositions containing them
IL77188A0 (en) Pharmaceutical compositions for the treatment of acquired immune deficiency syndrome and analogous syndromes
AU8815182A (en) 9,10-substituted 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro- 2h-pyrimido (6,1-a)isoquinolin-4-ones
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
JPS5244357A (en) Manufacturing method for a plastic retainer for a sliding bearing
PT86665A (pt) Process for the preparation of 14,15-substituted lanosterols and of hypocholesterolemic compositions containing the same
JPS5212864A (en) Method of measuring the center of gravity and device therefore
FR2477874B1 (fr) Composition de parfum a base de tricyclo (5.2.1.0.2,6) decane-2-carboxylate de methyle et son procede de preparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee